Cite
Additional file 4 of EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
MLA
Zhang, Zhen, et al. Additional File 4 of EPHA7 Mutation as a Predictive Biomarker for Immune Checkpoint Inhibitors in Multiple Cancers. Jan. 2021. EBSCOhost, https://doi.org/10.6084/m9.figshare.13685033.
APA
Zhang, Z., Hao-Xiang Wu, Wu-Hao Lin, Zi-Xian Wang, Yang, L.-P., Zhao-Lei Zeng, & Luo, H.-Y. (2021). Additional file 4 of EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers. https://doi.org/10.6084/m9.figshare.13685033
Chicago
Zhang, Zhen, Hao-Xiang Wu, Wu-Hao Lin, Zi-Xian Wang, Lu-Ping Yang, Zhao-Lei Zeng, and Hui-Yan Luo. 2021. “Additional File 4 of EPHA7 Mutation as a Predictive Biomarker for Immune Checkpoint Inhibitors in Multiple Cancers,” January. doi:10.6084/m9.figshare.13685033.